BioStamp nPoint device ( DrugBank: - )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 8 | ハンチントン病 | 1 |
8. ハンチントン病
臨床試験数 : 229 / 薬物数 : 193 - (DrugBank : 60) / 標的遺伝子数 : 84 - 標的パスウェイ数 : 158
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04201834 (ClinicalTrials.gov) | August 13, 2020 | 13/12/2019 | Risperidone for the Treatment of Huntington's Disease Involuntary Movements | Risperidone for the Treatment of Huntington's Disease Chorea | Huntington Disease;Chorea | Drug: Risperidone;Device: BioStamp nPoint device | University of Rochester | NULL | Recruiting | 18 Years | 65 Years | All | 12 | Phase 2 | United States |